Jeremy Lim
Directeur Général chez AMILI Pte Ltd.
Profil
Jeremy Lim founded AMILI Pte Ltd., where he worked as Chief Executive Officer.
Dr. Lim also currently works at HEAL Partners, as Advisor.
Dr. Lim received his graduate degree in 2003 from The Johns Hopkins University.
Postes actifs de Jeremy Lim
Sociétés | Poste | Début |
---|---|---|
AMILI Pte Ltd.
AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Directeur Général | - |
HEAL Partners
HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Consultant / Advisor | - |
Formation de Jeremy Lim
The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
AMILI Pte Ltd.
AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Health Technology |
HEAL Partners
HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Finance |